Fouad Atouf Appointed Chief Science Officer Of USP

Amanda Cowley to head commercial strategy as USP's new Chief Growth Officer

ROCKVILLE, Md., May 5, 2025 /PRNewswire/ -- The United States Pharmacopeia (USP) today announced several key leadership appointments and promotions, effective July 1, 2025.

Fouad Atouf, Ph.D. has been named Chief Science Officer, and Chair of the USP Council of Experts. "USP's commitment to science as the cornerstone of our efforts has established us globally as the leading provider of solutions for the most pressing quality challenges in medicines, dietary supplements, and food ingredients," said Atouf. " As lead of our staff scientists and volunteer body of independent experts, who work together to develop USP public quality standards, I aim to foster collaboration and innovative thinking to address emerging quality challenges and ensure our standards and solutions have a meaningful and timely impact."

In addition to his new roles, Atouf will continue to serve as interim head of Global Biologics. Jaap Venema, Ph.D., USP's current Chief Science Officer, will be leaving on June 30, 2025.

Amanda Cowley, J.D. has been appointed Chief Growth Officer and head of Regions, Programs and Strategy. "Reflecting on the needs of our stakeholders worldwide, we're dedicated to developing the right science-based solutions at the right time to help safeguard patients and consumers," said Cowley. "Together, we will focus on identifying and providing innovative reference standards and analytical materials solutions to support our documentary standards portfolios in critical areas such as microbial contamination, extractables and leachables, peptides, and cell and gene therapy."

Cowley succeeds Surendra Nath Koduru, Ph.D.—USP's current head of commercial strategy and operations—who announced his retirement earlier this year.

Ken Alexander, J.D. will take over from Amanda Cowley as General Counsel and will continue to serve as head of Global Legal.

"We deeply appreciate the contributions of Jaap and Surendra Nath, whose leadership has been invaluable in guiding us through transformative times," said Ronald T. Piervincenzi, Ph.D., USP's Chief Executive Officer. "As we welcome Fouad, Amanda, and Ken to their new roles, I am confident their perspectives will help drive evolution in medicine quality and developing impactful solutions for our stakeholders."

For more information, please contact: mediarelations@usp.org

About USP:

USP is an independent scientific organization that collaborates with the world's top experts in health and science to develop quality resources and standards for medicines, dietary supplements, and food ingredients. Through our resources, standards, advocacy and education, USP helps increase the availability of quality medicines, supplements and foods for billions of people worldwide.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fouad-atouf-appointed-chief-science-officer-of-usp-302445330.html

SOURCE U.S. Pharmacopeia

Frequently Asked Questions

Who is the new Chief Science Officer of USP?

Fouad Atouf, Ph.D., has been appointed as the new Chief Science Officer of USP.

What is Amanda Cowley's new role at USP?

Amanda Cowley, J.D., has been appointed as the new Chief Growth Officer and head of Regions, Programs and Strategy at USP.

When are these leadership changes effective?

These appointments are effective July 1, 2025.

First published on Tue, May 6, 2025

Enjoyed what you've read so far? Great news - there's more to explore!

Stay up to date with the latest news, a vast collection of tech articles including introductory guides, product reviews, trends and more, thought-provoking interviews, hottest AI blogs and entertaining tech memes.

Plus, get access to branded insights such as informative white papers, intriguing case studies, in-depth reports, enlightening videos and exciting events and webinars from industry-leading global brands.

Dive into TechDogs' treasure trove today and Know Your World of technology!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Tags:

USP Chief Science Officer Chief Growth Officer Pharmaceutical Technology Leadership Appointments Biologics Quality Standards

Join The Discussion

- Promoted By TechDogs -

Hiring